Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 5, 2016
In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratioHemda Baabur-Cohen, Laura Isabel Vossen, Harald Rune Krüger, et al.International Journal of Cancer|May 4, 2023
Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastomaPaula Ofek, Eilam Yeini, Gali Arad, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|January 7, 2018
Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancerEva Zupančič, Caterina Curato, Jung-Seok Kim, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 21, 2018
Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastasesInbal Zafir-Lavie, Shay Sherbo, Haim Goltsman, et al.Advanced Therapeutics|June 27, 2022
Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in MelanomaEvgeni Pisarevsky, Rachel Blau, Yana Epshtein, et al.Neuro-Oncology|January 31, 2025
IRS2 as a driver of brain metastasis in colorectal cancer: a potential target for novel therapeutic strategiesInbal Greenberg, Fayhaa Khair, Keren Merenbakh-Lamin, et al.Nature Nanotechnology|August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulatorsJoão Conniot, Anna Scomparin, Carina Peres, et al.Elife|October 5, 2017
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcomeShiran Ferber, Galia Tiram, Ana Sousa-Herves, et al.Nature Communications|March 27, 2021
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progressionEilam Yeini, Paula Ofek, Sabina Pozzi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 16, 2024
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linkerYulia Liubomirski, Galia Tiram, Anna Scomparin, et al.Pageof 3